Yuyu Pharma Inc (000227) — Capital Reinvestment Ratio
Yuyu Pharma Inc (000227) has a Capital Reinvestment Ratio of 1.75x as of September 2025, meaning it reinvests 2% of its operating cash flow (₩836.62 Million) in capital expenditures (₩1.46 Billion). Check 000227 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Yuyu Pharma Inc Capital Reinvestment Ratio (2014–2024)
This chart tracks Yuyu Pharma Inc's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Yuyu Pharma Inc.
Annual Capital Reinvestment Ratio for Yuyu Pharma Inc (2014–2024)
Year-by-year Capital Reinvestment Ratio for Yuyu Pharma Inc from 2014 to 2024. See Yuyu Pharma Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.29x | ₩24.95 Billion | ₩7.30 Billion | ▼ -97.6% |
| 2023 | 12.13x | ₩420.86 Million | ₩5.11 Billion | ▲ +800.7% |
| 2021 | 1.35x | ₩4.51 Billion | ₩6.07 Billion | ▲ +120.5% |
| 2019 | 0.61x | ₩13.19 Billion | ₩8.06 Billion | ▼ -61.8% |
| 2018 | 1.60x | ₩6.11 Billion | ₩9.76 Billion | ▼ -82.7% |
| 2017 | 9.25x | ₩561.35 Million | ₩5.19 Billion | ▲ +3819.4% |
| 2016 | 0.24x | ₩9.82 Billion | ₩2.32 Billion | ▼ -20.4% |
| 2014 | 0.30x | ₩1.36 Billion | ₩404.37 Million | — |